Page 57 - நிறுவனம் ஆஃப் புற்றுநோய் ஆராய்ச்சி News Today : Breaking News, Live Updates & Top Stories | Vimarsana

An existing drug could be used to treat aggressive forms of breast cancer - new research explained

An existing drug could be used to treat aggressive forms of breast cancer - new research explained
wigantoday.net - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wigantoday.net Daily Mail and Mail on Sunday newspapers.

United kingdomSimon vincentRachael natrajanInstitute of cancer researchBreast cancer nowCancer researchஒன்றுபட்டது கிஂக்டம்சிமோன் வின்சென்ட்ரேசல் நத்ராஜன்நிறுவனம் ஆஃப் புற்றுநோய் ஆராய்ச்சிமார்பக புற்றுநோய் இப்போதுபுற்றுநோய் ஆராய்ச்சி

Existing drug could treat aggressive triple-negative breast cancer – study | Burnham and Highbridge Weekly News

An already approved cancer drug could be used to treat more aggressive forms of breast cancer, new research has found. Researchers funded by Breast Cancer Now have identified a specific defect in some triple-negative breast cancers and a pre-existing drug that could help treat the disease. The new research, led by Dr Rachael Natrajan at The Institute of Cancer Research, discovered a way to identify triple-negative breast tumours that could be more likely to respond to a class of drugs called CDK4/6 inhibitors, including palbociclib. Palbociclib is currently used to treat other breast cancers that have spread to a different part of the body. However, the research found there is the potential to use the drug to treat around a fifth of people living with triple-negative breast cancer.

United kingdomSimon vincentRachael natrajanInstitute of cancer researchBreast cancer nowCancer researchஒன்றுபட்டது கிஂக்டம்சிமோன் வின்சென்ட்ரேசல் நத்ராஜன்நிறுவனம் ஆஃப் புற்றுநோய் ஆராய்ச்சிமார்பக புற்றுநோய் இப்போதுபுற்றுநோய் ஆராய்ச்சி

Medical breakthrough could help thousands in UK living with an aggressive type of breast cancer

Medical breakthrough could help thousands in UK living with an aggressive type of breast cancer Maya Oppenheim © Provided by The Independent Thousands of women living in the UK suffering from an aggressive type of breast cancer could be helped by a newly identified drug, according to a study. The research, carried out by The Institute of Cancer Research, found medicine presently used to help other breast cancers that have spread to another area of the body, could actually be utilised to help around a fifth of women who have triple negative breast cancer. Around 55,000 women are diagnosed with breast cancer in Britain each year, with approximately one in five of these being triple negative. Younger women and black women are more likely to develop this form of breast cancer which is generally more aggressive.

United kingdomSimon vincentRachael natrajanInstitute of cancer researchCancer researchBreast cancer nowLondon based instituteCancer nowஒன்றுபட்டது கிஂக்டம்சிமோன் வின்சென்ட்ரேசல் நத்ராஜன்நிறுவனம் ஆஃப் புற்றுநோய் ஆராய்ச்சிபுற்றுநோய் ஆராய்ச்சிமார்பக புற்றுநோய் இப்போதுலண்டன் அடிப்படையிலானது நிறுவனம்புற்றுநோய் இப்போது

Aggressive breast cancers could be fought with drug already being used in treatment

The medication is currently used on other breast tumours that have spread through the body. But the researchers found the potential to use it to treat around a fifth of people with triple-negative breast cancer. Dr Natrajan said the study “suggests the exciting possibility that an already-approved breast cancer drug could be used to help women with this type of disease”. Clinical trials will take several years but if they are successful, CDK4/6 inhibitors could be used within five years. Triple-negative breast cancer refers to tumours lacking three molecules normally used to classify it – oestrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2) protein.

United kingdomElizabeth hurleySimon vincentRachael natrajanInstitute of cancer researchBreast cancer nowCancer researchPrivacy noticeஒன்றுபட்டது கிஂக்டம்எலிசபெத் ஹர்லிசிமோன் வின்சென்ட்ரேசல் நத்ராஜன்நிறுவனம் ஆஃப் புற்றுநோய் ஆராய்ச்சிமார்பக புற்றுநோய் இப்போதுபுற்றுநோய் ஆராய்ச்சிப்ரைவஸீ அறிவிப்பு

Existing drug offers targeted treatment for aggressive breast cancer

Existing drug offers targeted treatment for aggressive breast cancer
pharmaceutical-business-review.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pharmaceutical-business-review.com Daily Mail and Mail on Sunday newspapers.

United kingdomCity ofRachael natrajanCancer researchBreast cancer now toby robins research centreInstitute of cancer researchInstitute of cancer research functional genomicsBreast cancer nowCancer research functional genomicsஒன்றுபட்டது கிஂக்டம்நகரம் ஆஃப்ரேசல் நத்ராஜன்புற்றுநோய் ஆராய்ச்சிமார்பக புற்றுநோய் இப்போது டோபி ராபின்ஸ் ஆராய்ச்சி மையம்நிறுவனம் ஆஃப் புற்றுநோய் ஆராய்ச்சிநிறுவனம் ஆஃப் புற்றுநோய் ஆராய்ச்சி செயல்பாட்டு மரபியல்